The PXR rs7643645 Polymorphism Is Associated with the Risk of Higher Prostate-Specific Antigen Levels in Prostate Cancer Patients.

MLA

Reyes-Hernández, Octavio D., et al. “The PXR Rs7643645 Polymorphism Is Associated with the Risk of Higher Prostate-Specific Antigen Levels in Prostate Cancer Patients.” PLoS ONE, vol. 9, no. 6, June 2014, pp. 1–8. EBSCOhost, https://doi.org/10.1371/journal.pone.0099974.

APA

Reyes-Hernández, O. D., Vega, L., Jiménez-Ríos, M. A., Martínez-Cervera, P. F., Lugo-García, J. A., Hernández-Cadena, L., Ostrosky-Wegman, P., Orozco, L., & Elizondo, G. (2014). The PXR rs7643645 Polymorphism Is Associated with the Risk of Higher Prostate-Specific Antigen Levels in Prostate Cancer Patients. PLoS ONE, 9(6), 1–8. https://doi.org/10.1371/journal.pone.0099974

Chicago

Reyes-Hernández, Octavio D., Libia Vega, Miguel A. Jiménez-Ríos, Pedro F. Martínez-Cervera, Juan A. Lugo-García, Leticia Hernández-Cadena, Patricia Ostrosky-Wegman, Lorena Orozco, and Guillermo Elizondo. 2014. “The PXR Rs7643645 Polymorphism Is Associated with the Risk of Higher Prostate-Specific Antigen Levels in Prostate Cancer Patients.” PLoS ONE 9 (6): 1–8. doi:10.1371/journal.pone.0099974.